Underweight as a Risk Factor for Major Intra-abdominal Malignancy Surgeries.

Cureus

Division of Anaesthesiology and Perioperative Medicine, Singapore General Hospital, Singapore, SGP.

Published: October 2024


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Purpose The relationship between body mass index (BMI) and postoperative outcomes for oncology surgeries among the Asian population remains controversial. A prevailing perception suggests that excess adiposity is associated with reduced cancer survival. However, several reports have shown that overweight or early obese states confer better survival outcomes. It is hypothesized that patients with better nutrition and surplus calories grant survival advantages to radical cancer treatment. The purpose of this study is to examine the relationship between BMI and postoperative 30-day and one-year mortality in the Asian population. Methods This retrospective review investigates the postoperative mortality, intensive care unit (ICU) admission, and length of hospital stay following major abdominal cancer surgeries within the Asian population. Patients were stratified into three groups based on their BMI: underweight (BMI < 18.5 kg/m), normal weight (BMI 18.5-27.5 kg/m), and obese (BMI > 27.5 kg/m). Results A total of 646 patients were included in this study. At 30 days, the underweight group presents an 8% mortality compared to 1% and 3% mortality in the normal BMI and obese groups, respectively. At one year, the low BMI group presents a significant increase in mortality of 53% as opposed to the normal BMI and obese group with mortality rates of 14% and 12%, respectively (p < 0.001). There is a significant increase in the ICU admission rate in the underweight group (n = 13, 25%) compared to the normal BMI and obese groups (n = 26, 6%; n = 8, 6% p < 0.001). Similarly, the group with lower BMI was observed to require a longer hospital stay postoperatively (median (IQR) 11.0 (4.0-24.0)) compared to the normal (median (IQR) 4.0 (3.0-9.0)) and obese (median (IQR) 4.5 (3.0-8.0)) patients. Conclusion Concordant results were observed in the underweight patient group with increased one-year mortality, ICU admission rate, and hospital stay postoperatively. Low BMI presents as an independent risk factor for major radical surgeries.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11570910PMC
http://dx.doi.org/10.7759/cureus.71835DOI Listing

Publication Analysis

Top Keywords

bmi
12
asian population
12
icu admission
12
hospital stay
12
normal bmi
12
bmi obese
12
median iqr
12
risk factor
8
factor major
8
bmi postoperative
8

Similar Publications

Importance: The cardiovascular benefits of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) may vary by body mass index (BMI), but evidence on BMI-specific outcomes remains limited.

Objective: To investigate the associations of GLP-1 RA use with cardiovascular and kidney outcomes across BMI categories in patients with type 2 diabetes.

Design, Setting, And Participants: This retrospective cohort study used the Chang Gung Research Database, a clinical dataset covering multiple hospitals in Taiwan.

View Article and Find Full Text PDF

The Impact of Obesity and Overweight on Rheumatoid Arthritis Patients: Real-World Insights from a Biologic and Targeted Synthetic DMARDs Registry. The management of rheumatoid arthritis (RA) has advanced with biological and targeted synthetic disease-modifying anti-rheumatic drugs (b/tsDMARDs). However, obesity, a common comorbidity, impacts treatment and disease progression efficacy.

View Article and Find Full Text PDF

The coexistence of chronic hepatitis B (CHB) and metabolic dysfunction-associated liver disease (MASLD) gained recognition, but the diagnostic performance of non-invasive markers regarding it remains underexplored. This study aimed to evaluate the utility of the FIB-4 index for fibrosis prediction in CHB patients and investigate its performance in the distinct subgroup of CHB-MASLD. A prospective study from 2021 to 2022 included 109 CHB and 64 CHB-MASLD patients.

View Article and Find Full Text PDF

Serum Proteomic Profile Based on the TGF-β Pathway Stratifies Risk of Hepatocellular Carcinoma.

Liver Int

October 2025

Division of Gastroenterology and Hepatology, Department of Medicine, The Institute for Bioelectronic Medicine, Feinstein Institutes for Medical Research & Cold Spring Harbor Laboratory, Northwell Health, Manhasset, New York, USA.

Background: Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related deaths, primarily due to late-stage diagnosis. In this multicenter study, our goal is to identify functional biomarkers that stratify the risk of HCC in patients with cirrhosis (CP) for early diagnosis.

Methods: Five thousand and eight serum proteins (Somascan) were analysed in Cohort A (477 CP, including 125 HCC).

View Article and Find Full Text PDF

The Association Between a Body Shape Index and Testosterone Among U.S. Adult Males: National Health and Nutrition Examination Survey (2011-2016).

Int J Vitam Nutr Res

July 2025

Department of Urology and Andrology, The First Affiliated Hospital, Sun Yat-sen University, 510080 Guangzhou, Guangdong, China.

Background: Obesity, a prevalent global health issue, is associated with testosterone deficiency (TD). A body shape index (ABSI) provides a more precise assessment of obesity and visceral fat, but its relationship with testosterone remains unclear. This study aimed to explore the association between ABSI and testosterone levels leading to TD.

View Article and Find Full Text PDF